This June in Shanghai, the 24th World Pharmaceutical Raw Materials China Exhibition (CPHI China 2026) took place at the Shanghai New International Expo Centre. This landmark industry gathering brought together pharmaceutical enterprises, practitioners, experts and scholars from the global pharma sector. Sichuan Xieli Pharmaceutical Co., Ltd. joined the event as an invited exhibitor, showcasing its full product portfolio, application solutions for natural extracts and complete CDMO service system, while holding in-depth discussions with domestic and overseas industry peers.
For this exhibition, Xieli presented its offerings across three core showcase pillars: APIs, natural extracts, and tailored CDMO services. Our booth features a sleek, professional, international-style layout with dedicated zones for product display and one-on-one business negotiations. We welcomed a steady stream of industry visitors and partners from Europe, the Americas, Asia and the Middle East, with lively, productive conversations taking place throughout the event.
As a pharmaceutical manufacturer with long-standing expertise in natural products and specialty APIs, our core product lineup drew strong industry interest throughout the exhibition. Our full range of bile acid products is backed by mature manufacturing processes and complete quality control systems, suitable for hepatobiliary drug R&D and other applications, with on-demand technical support and custom services available. Our flavonoid extract series- including Hesperidin, Diosmin, Rutin and Troxerutin- delivers stable supplies of natural APIs for downstream partners via full-process quality management.。
For oncology drug development, Xieli presented its camptothecin API and intermediate products. Leveraging continuously optimized production processes and stringent quality standards, we guarantee consistent product quality and reliable long-term supply capacity.
On the custom solutions front, Xieli’s end-to-end CDMO service platform also emerged as a key focal point for on-site discussions. Backed by our in-house R&D team, pilot production lines and large-scale manufacturing facilities, we deliver full-cycle support spanning process development, process optimization, analytical method development, regulatory filing and commercial manufacturing. Our services cover APIs, high-value intermediates and natural extracts, designed to accelerate project delivery for our partners.
Throughout the exhibition, existing and prospective partners visited our booth in large numbers, holding in-depth discussions on industry trends, raw material applications, domestic and international regulatory requirements, and collaborative project development. This event not only enabled Xieli to strengthen our long-standing partnerships, but also allowed us to forge connections with a wide range of new industry peers, laying a solid foundation for our future global market expansion.
As the premier global hub connecting resources across the pharmaceutical industry, CPHI serves as a vital bridge for international collaboration. Our participation this year has showcased Xieli’s full spectrum of capabilities across natural extracts, specialty APIs and CDMO services. Going forward, Xieli Pharmaceutical will remain committed to our core principles of "Rooted in Quality, Powered by Innovation, Committed to Mutual Success". We will continue to advance our R&D and service capabilities, working hand-in-hand with global partners to drive steady, sustainable growth for the global pharmaceutical industry.
Important Notice: All products referenced in this article are pharmaceutical APIs, intermediates and natural extracts, intended for industrial production and processing purposes only. They are not finished pharmaceutical products and must not be used directly by end users.
Contact Us
Foreign Trade:+86-28-83188601
Domestic Trade：+86-28-83188610
E-mail:sales@xielipharm.com
